Check the Batch
Class IIITerminated in FDA datasetRecall initiated May 6, 2019

Item FG 10146, Barlean s, Essential Woman

Recalling firm: Barlean's Llc

Why it was recalled

Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 15, 2020.

Check your package

Compare the exact product and package details with the label you have.

ProductItem FG 10146, Barlean s, Essential Woman, 120 count Softgels per bottle, UPC 7 05875 10013 7. Item FG 10147, Barlean s, Essential Woman, 60 count Softgels per bottle, UPC 7 05875 10009 0.
UPC705875100090, 705875100137

FDA code information

Best By of January 2022 and earlier

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Item FG 10146, Barlean s, Essential Woman, 120 count Softgels per bottle, UPC 7 05875 10013 7. Item FG 10147, Barlean s, Essential Woman, 60 count Softgels per bottle, UPC 7 05875 10009 0.

Extracted codes and context

TypeCode / valueContext
UPC705875100090 Item FG 10147, Barlean s, Essential Woman, 60 count Softgels per bottle, UPC 7 05875 10009 0.
UPC705875100137Item FG 10146, Barlean s, Essential Woman, 120 count Softgels per bottle, UPC 7 05875 10013 7. Item FG 10147, Barlean s, Essential Woman, 60 count Softgels per bottle, UPC 7 05875 10009 0.

Original FDA recall reason

Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.

Recall details

Recall number
F-1366-2019
Event ID
82565
FDA status
Terminated
Initiated
May 6, 2019
Reported
May 22, 2019
Classified
May 16, 2019
Terminated
Oct 15, 2020
Quantity
1144 bottles (FG 10146) and 1913 bottles (FG 10147)
Location
Ferndale, WA, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

nationwide

FDA source record · F-1366-2019

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.